Skip to content
Translational Neuropharmacology Lab (Zanos Lab)

Translational Neuropharmacology Lab (Zanos Lab)

Our laboratory, based in Cyprus, employs molecular and systems neuroscience, behavioral pharmacology, as well as advanced computational methods to unravel the mysteries of brain diseases and identify targets for the development of novel and effective pharmacotherapies.

Menu
  • Home
  • News
  • Team Members
    • Lab Director
    • Current Team Members
    • Alumni
  • Research
  • Research Units
    • Translational Neuropharmacology Unit
    • Clinical Neuropsychopharmacology Unit
    • AI & Systems Bioinformatics Unit Cyprus
    • Genetic Epidemiology Unit
  • Facilities
  • Publications
  • Media
  • Join Us
  • Contact
  • More

Mr. Stylianos Valiantis

Stylianos Valiantis, BSc, MSc

Ph.D. Student

Stylianos holds a B.Sc. in Psychology from Aristotle University of Thessaloniki, Greece, an M.Sc. in Neuroscience from Cyprus Institute of Neurology and Genetics in Nicosia, Cyprus, and is currently a Ph.D. student in Clinical Psychology at the University of Cyprus in Nicosia, Cyprus.

His Ph.D. research project focuses on nicotine relapse vulnerability, specifically involving the investigation of neurobiophysiological markers to better understand the associated risks.

Research Interests: His research interests primarily revolve around the study of brain-behavior relationships, particularly focusing on behavioral expressions as an indicator of nervous system pathology. He has been involved in various projects that examine behavioral and neuroendocrine responses to different conditions, including enriched environments and stressful events, with the aim of identifying mechanisms associated with mental disorders like anxiety and depression. These projects involved the use of animal models, which underwent both histological and behavioral tests. Additionally, he has been part of a project that investigates the impact of Alzheimer’s Disease-derived brain pathology on fine motor function. This research involved the use of transgenic animal models and various techniques, including PCR and behavioral analyses, to draw conclusions regarding the disturbance of fine motor function observed in this disorder.

Selected Publications:

  • Valiantis, S., Perentos, N., Koupparis, A.M., Hadjipapas. A., Papacostas, S.S., Kousiappa, I. (2026). Fine motor function deficits in the 5xFAD mouse model of Alzheimer’s disease. Behavioral Brain Research.https://doi.org/10.1016/j.bbr.2026.116097.

Contact Info:

Email: valiantis.stylianos@ucy.ac.cy

Recent Posts

  • New manuscript: The Immunosuppression Paradox in Multiple Sclerosis: Are We Fueling the Fire by Suppressing Immunity in an Epstein–Barr Virus–Linked Disease? March 12, 2026
  • New Preprint article – From Heatwaves to Brainwaves: Climate-Driven Microplastics Promote Epstein–Barr Virus Reactivation and Female-Biased Risk for Alzheimer’s Disease and Multiple Sclerosis February 24, 2026
  • New Publication – Linking Misophonia and Tinnitus: Common and Divergent Neurobiological Mechanisms January 29, 2026
  • Dr. Zanos Appointed to the Editorial Board of the Neuropharmacology Journal January 17, 2026
  • Zanos lab publishes a short review article on Major Depressive Disorder in Trends in Molecular Medicine January 4, 2026

Navigation

  • Home
  • News
  • Team Members
    • Lab Director
    • Current Team Members
    • Alumni
  • Research
  • Research Units
    • Translational Neuropharmacology Unit
    • Clinical Neuropsychopharmacology Unit
    • AI & Systems Bioinformatics Unit Cyprus
    • Genetic Epidemiology Unit
  • Facilities
  • Publications
  • Media
  • Join Us
  • Contact
  • More

Translational Neuropharmacology Lab (Zanos Lab) 2026 . Powered by WordPress